What is VitVio?
VitVio operates at the intersection of deep tech and medical innovation, providing an autonomous platform designed to optimize the efficiency and quality of care in operating rooms. By utilizing sophisticated computer vision and machine learning algorithms, the platform offers real-time surgery progress monitoring and automated staff training modules. This technology is engineered for seamless integration with existing hospital systems, ensuring that clinical operations remain uninterrupted while providing actionable insights that improve surgical outcomes. VitVio's commitment to HIPAA and GDPR compliance positions it as a secure, scalable solution for healthcare providers seeking to modernize their surgical suites through data-driven intelligence.
How much funding has VitVio raised?
VitVio has raised a total of $9.8M across 2 funding rounds:
Other Financing Round
$1.8M
Seed
$8M
Other Financing Round (2025): $1.8M with participation from Tiny Supercomputer Investment, Bek Ventures, and LDV Capital
Seed (2025): $8M led by Tiny VC, Balnord, Thornapple River Capital, and Bek Ventures
Key Investors in VitVio
Tiny Supercomputer Investment
A specialized firm focusing on ambitious, early-stage technology startups, particularly within the European ecosystem, providing foundational support and founder-led networking.
Bek Ventures
A venture firm with over a decade of experience, dedicated to partnering with a select group of early-stage founders to provide strategic guidance and operational support.
LDV Capital
An investment firm that collaborates with deep tech teams developing businesses powered by visual technology, computer vision, and artificial intelligence.
What's next for VitVio?
With the recent capital injection, VitVio is well-positioned to accelerate its product roadmap and expand its footprint within the global healthcare market. The strategic focus will likely shift toward scaling its enterprise-grade software, enhancing the predictive capabilities of its AI models, and deepening its integration partnerships with major hospital networks. As the company matures, the emphasis will remain on demonstrating measurable improvements in surgical efficiency and cost reduction, which are essential for long-term adoption in the competitive medical technology landscape. Future growth will be defined by the company's ability to translate its technical prowess into sustained clinical value, potentially setting a new standard for autonomous surgical support.
See full VitVio company page
